The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia S Eghbal‐Fard, M Yousefi, H Heydarlou, M Ahmadi, S Taghavi, ... Journal of Cellular Physiology 234 (4), 5106-5116, 2019 | 123 | 2019 |
Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts R Rikhtegar, M Pezeshkian, S Dolati, N Safaie, AA Rad, M Mahdipour, ... Biomedicine & Pharmacotherapy 109, 304-313, 2019 | 109 | 2019 |
The role of magnesium in pathophysiology and migraine treatment S Dolati, R Rikhtegar, A Mehdizadeh, M Yousefi Biological trace element research 196, 375-383, 2020 | 89 | 2020 |
Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis S Dolati, Z Babaloo, H Ayromlou, M Ahmadi, R Rikhtegar, ... Journal of neuroimmunology 327, 15-21, 2019 | 84 | 2019 |
Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators S Dolati, M Ahmadi, L Aghebti-Maleki, A Nikmaram, F Marofi, R Rikhtegar, ... Pharmacological reports 70 (6), 1158-1167, 2018 | 81 | 2018 |
Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis S Dolati, M Ahmadi, R Rikhtegar, Z Babaloo, H Ayromlou, ... International immunopharmacology 61, 74-81, 2018 | 63 | 2018 |
The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial DS Oskouei, R Rikhtegar, M Hashemilar, H Sadeghi-Bazargani, ... Journal of Stroke and Cerebrovascular Diseases 22 (8), e557-e563, 2013 | 60 | 2013 |
Altered T‐cell subpopulations in recurrent pregnancy loss patients with cellular immune abnormalities S Abdolmohammadi Vahid, M Ghaebi, M Ahmadi, M Nouri, S Danaei, ... Journal of cellular physiology 234 (4), 4924-4933, 2019 | 54 | 2019 |
Dysregulated network of miRNAs involved in the pathogenesis of multiple sclerosis S Dolati, F Marofi, Z Babaloo, L Aghebati-Maleki, L Roshangar, M Ahmadi, ... Biomedicine & Pharmacotherapy 104, 280-290, 2018 | 54 | 2018 |
NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss M Ahmadi, M Ghaebi, S Abdolmohammadi‐Vahid, S Abbaspour‐Aghdam, ... Journal of Cellular Physiology 234 (6), 9428-9437, 2019 | 52 | 2019 |
Effectiveness of very low profile thrombectomy device in primary distal medium vessel occlusion, as rescue therapy after incomplete proximal recanalization or following … R Rikhtegar, PJ Mosimann, R Weber, M Wallocha, E Yamac, ... Journal of neurointerventional surgery 13 (12), 1067-1072, 2021 | 47 | 2021 |
Stroke subtypes, risk factors and mortality rate in northwest of Iran M Farhoudi, K Mehrvar, H Sadeghi-Bazargani, M Hashemilar, ... Iranian journal of neurology 16 (3), 112, 2017 | 40 | 2017 |
Stem cell‐based cell therapy for neuroprotection in stroke: A review R Rikhtegar, M Yousefi, S Dolati, HD Kasmaei, S Charsouei, M Nouri, ... Journal of cellular biochemistry 120 (6), 8849-8862, 2019 | 38 | 2019 |
Efficacy of citalopram on acute ischemic stroke outcome: a randomized clinical trial D Savadi Oskouie, E Sharifipour, H Sadeghi Bazargani, M Hashemilar, ... Neurorehabilitation and Neural Repair 31 (7), 638-647, 2017 | 36 | 2017 |
Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression A Mahmoodpoor, M Hosseini, S Soltani-Zangbar, S Sanaie, ... Molecular immunology 138, 121-127, 2021 | 34 | 2021 |
The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double‐blind, placebo‐controlled clinical trial M Ahmadi, M Hajialilo, S Dolati, S Eghbal‐Fard, H Heydarlou, M Ghaebi, ... Journal of Cellular Biochemistry 121 (1), 103-110, 2020 | 34 | 2020 |
Allopurinol as a preventive contrivance after acute ischemic stroke in patients with a high level of serum uric acid: a randomized, controlled trial AA Taheraghdam, E Sharifipour, A Pashapour, S Namdar, A Hatami, ... Medical Principles and Practice 23 (2), 134-139, 2014 | 32 | 2014 |
Simple In‐Hospital Interventions to Reduce Door‐to‐CT Time in Acute Stroke E Sadeghi-Hokmabadi, A Taheraghdam, M Hashemilar, R Rikhtegar, ... International journal of vascular medicine 2016 (1), 1656212, 2016 | 26 | 2016 |
Effect of IMOD™ on the inflammatory process after acute ischemic stroke: a randomized clinical trial M Farhoudi, M Najafi-Nesheli, M Hashemilar, A Mahmoodpoor, ... DARU Journal of Pharmaceutical Sciences 21, 1-8, 2013 | 24 | 2013 |
Predicting 30-day mortality in patients with primary intracerebral hemorrhage: Evaluation of the value of intracerebral hemorrhage and modified new intracerebral hemorrhage scores F Rahmani, R Rikhtegar, A Ala, A Farkhad-Rasooli, H Ebrahimi-Bakhtavar Iranian journal of neurology 17 (1), 47, 2018 | 23 | 2018 |